- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8555
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,555 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
HTL | PK₨39.58 | 0.3% | 68.7% | PK₨5.5b | PK₨63.60 | PB1x | E48.3% | 0% | Capital Goods | ||
RHM | €510.20 | -2.5% | 100.8% | €22.2b | €616.44 | PE34x | E27.7% | 1.1% | Capital Goods | ||
MVW | NOK 10.80 | -2.7% | 22.7% | NOK 353.4m | NOK 13.00 | PS32.7x | E69.2% | n/a | Materials | ||
KEBNI B | SEK 1.21 | -5.9% | -1.8% | SEK 329.2m | SEK 2.20 | PS2.9x | E86.1% | n/a | Tech | ||
ADOC | €5.52 | -3.7% | -45.7% | €83.0m | €6.30 | PS13.7x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
FWRY | ج.م7.60 | -1.3% | 35.0% | ج.م25.9b | ج.م10.92 | PE26.9x | E31.0% | n/a | Diversified Financials | ||
NEWBRY | SEK 3.10 | -3.1% | -20.5% | SEK 75.2m | SEK 8.00 | PS4.1x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
CALTX | SEK 207.60 | 0.2% | 144.5% | SEK 11.2b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
GGP | UK£0.051 | -25.0% | -16.4% | UK£259.6m | n/a | PB5.2x | E48.8% | n/a | Materials | ||
AGP | €6.49 | -1.2% | 67.7% | €112.4m | €12.75 | PE22.8x | E22.8% | n/a | Capital Goods | ||
MBTN | CHF 1.79 | -1.5% | -99.4% | CHF 55.2m | CHF 6.03 | PB0.3x | E95.4% | n/a | Semiconductors | ||
RMDA | ج.م2.44 | -4.3% | 72.0% | ج.م3.7b | ج.م4.38 | PE16.2x | E30.3% | 2.7% | Pharmaceuticals & Biotech | ||
CADLR | NOK 68.10 | 1.6% | 77.8% | NOK 23.9b | NOK 81.94 | PS16.2x | E67.8% | n/a | Capital Goods | ||
AFISH | NOK 45.00 | -6.6% | -52.1% | NOK 1.4b | NOK 81.00 | PS1.4x | E98.9% | n/a | Food, Beverage & Tobacco | ||
SCOL | SEK 0.15 | 0.7% | -90.4% | SEK 34.1m | n/a | PB0.7x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$46.42 | 1.6% | 60.0% | US$14.9b | US$47.10 | PE82.2x | E24.4% | n/a | Consumer Durables | ||
ASND | US$112.93 | -5.5% | 12.7% | US$6.5b | US$182.64 | PS18.5x | E68.4% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$7.39 | 2.8% | 46.0% | US$388.8m | US$18.00 | PS16.4x | E69.4% | n/a | Pharmaceuticals & Biotech | ||
AOT | CA$0.16 | -66.0% | -62.4% | CA$113.0m | n/a | PS46.7x | E46.9% | n/a | Materials | ||
AESI | US$19.81 | -1.1% | -14.9% | US$2.2b | US$26.00 | PE14.9x | E42.1% | 4.6% | Energy | ||
GTHX | US$7.13 | 0% | 348.4% | US$377.1m | US$7.15 | PS6.5x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$26.65 | -14.9% | 76.8% | US$4.4b | US$35.08 | PS20.3x | E95.9% | n/a | Semiconductors | ||
ARES | US$141.46 | 0.4% | 34.3% | US$44.1b | US$149.75 | PE74.7x | E32.4% | 2.6% | Diversified Financials | ||
GAU | CA$1.92 | 5.5% | 125.9% | CA$493.3m | CA$3.30 | PE37.5x | E31.2% | n/a | Materials |